Cardio,Cardiovascular News,Cardiologists,Medicines,Heart Health,EKG

* Internet Search Results

*** Search Filter: "Vermont"

Vermont - Wikipedia
Vermont - Wikipedia

23 Top Things to Do in Vermont - U.S. News Travel
Looking for the best things to do in Vermont? From sailing on Lake Champlain to taking a factory tour of Ben & Jerry's, these are the most iconic experiences.

Vermont | Geography, Capital, Population, History, & Facts | Britannica
Vermont, constituent state of the United States, one of the six New England states lying in the northeastern corner of the country. The 14th state admitted to the union (on March 4, 1791), its capital is Montpelier. Learn more about the history and features of Vermont in this article.

Vermont Vacation | Vermont Tourism
Vermont’s way of life is defined by unhurried rhythms, open-minded culture, and a dynamic spirit. Visiting Vermont offers space to reconnect with the natural

Home | Vermont.gov
Welcome to Vermont What can we help you find? Online Services VT-Alert Agencies (A -Z)

Geography of Vermont - Wikipedia
Vermont's extremely rugged terrain is the almost certain explanation for why the state has remained so sparsely populated; After Maine, Vermont has the lowest population density of any state east of the Mississippi River. Burlington, at only ~45,000 people is the largest city, and is situated in the (relatively) flat and populated Champlain Valley.

A Massive Vermont Bucket List to Help You Explore More in Every Season
Whether you’re a die-hard adventurer, a foodie traveler, or a meandering road tripper, you’ll find no shortage of amazing things to do in Vermont. There are so many things to do in Vermont in every season! Yes, Vermont is one of the smallest states, both geographically and by population, but it’s got a lot going for it, and if you add these items to your Vermont bucket list, you’ll ...

Plan your Vermont Vacation: Lodging, Food, Events & Things To Do
Vermont.com offers everything you need to plan the perfect Vermont vacation. From local attractions, travel guides, lodging, dining and more!

Vermont: The Green Mountain State - Visit The USA
The Green Mountain State Nature sets the stage in Vermont. Picture-perfect hikes, fall foliage and cozy ski towns thrive in a place where roadside billboards are banned statewide, leaving mountain and village views beautifully uncluttered. Relaxation and exploration shine across beautiful landscapes and charming, locally flavored communities.

Things to Do | Vermont Tourism
Vermont, with its charming towns, lush landscapes, and vibrant culture, offers a perfect escape for nature enthusiasts and adventure seekers alike. These guides point you to the best things to do in Vermont year-round, from the stunning fall foliage, the winter wonderland of snow-covered landscapes, or the blooming beauty of spring and summer.

* Latest OCD 101 News

*** News Filter: "Vermont"

Noah Kahan Became a Superstar By Being Himself  Rolling Stone
A rare condition can send kids into fits of rage. Treatment could help — if insurance covers it.  VTDigger
Noah Kahan was crowned a superstar. It messed with his head  bbc.com
The Great Divide review | Noah Kahan goes home, gets told to leave, and writes 17 songs about it  whynow
Comedian Adam Strauss at Next Stage  The Vermont Journal & The Shopper -
‘The Great Divide’ by Noah Kahan - Lyrics & Meaning  Holler Country
How Matt’s Loss Made Him Stronger  Child Mind Institute
Sister Jeanne Marie Gonyon, OCD  Burlington Free Press
New book Light illuminates anorexia recovery  Vermont Business Magazine
Robert J. Traynor Obituary Nov 29, 2017  Goss Funeral Services
Stop romanticizing mental illness  The Vermont Cynic
‘I Needed Help’: A Young Woman’s Story of Battling Anxiety  Valley News
Report Details Alleged Abuse At State Mental Hospital  Vermont Public
How Skiing Transformed My Mental Health  skimag.com
Brain Inflammation Discovered in Those With OCD  Neuroscience News

Common Cardiovascular Symptoms & Warning Signs

Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

Current Cardiovascular Treatments

Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.

Key Milestones in Cardiovascular History

Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.

Current Cardiovascular Research & Breakthroughs

Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.